DSE : PHARMAID
Pharma Aids Limited — Financial statements
Pharmaceutical Preparations · Bangladesh
Last price 544.6 BDT (At close: Oct 29, 2026) · Market cap 1.70B
Latest research: Pharma Aids financial analysis: 9M FY2026 sales up 17.6%, sponsors at 19.38% (Oct 2026) · Pharma Aids: FY2025 net sales of BDT 438m, 9M FY2026 sales up 17.6% and profit up 28.1%, sponsors at 19.38%
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Financial statements
Pharma Aids Limited (PHARMAID) reported revenue of 495.70M BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 495.70M | 438.09M | 421.23M | 308.49M | 323.05M | 280.29M |
| Cost of Revenue | 340.03M | 306.09M | 291.88M | 257.20M | 219.58M | 174.95M |
| Gross Profit | 155.67M | 131.99M | 129.36M | 51.29M | 103.47M | 105.34M |
| Selling, General & Admin | 48.52M | 45.49M | 44.03M | 37.32M | 45.63M | 38.17M |
| Other Operating Expenses | 77.73K | 138.35K | 65.53K | 2.21M | 1.94M | 74.76K |
| Operating Expenses | 51.59M | 48.58M | 44.99M | 40.63M | 49.45M | 39.02M |
| Operating Income | 104.09M | 83.41M | 84.36M | 10.66M | 54.02M | 66.33M |
| Interest Expense | -2.44M | -1.75M | -258.22K | -239.20K | -381.90K | -899.72K |
| Interest & Investment Income | 239.36K | 359.39K | 621.55K | |||
| Other Non Operating Income (Expenses) | -108.97K | -67.34K | -161.53K | -127.62K | -88.92K | -71.58K |
| EBT Excluding Unusual Items | 101.78M | 81.96M | 84.56M | 10.30M | 53.54M | 65.35M |
| Gain (Loss) on Sale of Assets | -10.13K | 366.26K | ||||
| Pretax Income | 101.77M | 82.32M | 84.56M | 10.30M | 53.54M | 65.35M |
| Income Tax Expense | 24.12M | 18.51M | 23.38M | 16.68M | 18.78M | 15.10M |
| Net Income | 77.65M | 63.82M | 61.19M | -6.38M | 34.76M | 50.26M |
| Net Income to Common | 77.65M | 63.82M | 61.19M | -6.38M | 34.76M | 50.26M |
| Shares Outstanding (Basic) | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M |
| Shares Outstanding (Diluted) | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M |
| EPS (Basic) | 24.89 | 20.45 | 19.61 | -2.05 | 11.14 | 16.11 |
| EPS (Diluted) | 24.89 | 20.45 | 19.61 | -2.05 | 11.14 | 16.11 |
| Free Cash Flow | 6.74M | -17.37M | 22.60M | 5.06M | 29.15M | 21.12M |
| Free Cash Flow Per Share | 2.16 | -5.57 | 7.25 | 1.62 | 9.34 | 6.77 |
| Dividend Per Share | 3.00 | 3.00 | 2.50 | 1.00 | 5.00 | 5.00 |
| Gross Margin | 31.41% | 30.13% | 30.71% | 16.63% | 32.03% | 37.58% |
| Operating Margin | 21.00% | 19.04% | 20.03% | 3.46% | 16.72% | 23.66% |
| Profit Margin | 15.66% | 14.57% | 14.53% | -2.07% | 10.76% | 17.93% |
| Free Cash Flow Margin | 1.36% | -3.97% | 5.37% | 1.64% | 9.02% | 7.54% |
| EBITDA | 113.59M | 89.91M | 91.28M | 18.29M | 61.84M | 74.58M |
| EBITDA Margin | 22.92% | 20.52% | 21.67% | 5.93% | 19.14% | 26.61% |
| D&A For EBITDA | 9.51M | 6.50M | 6.92M | 7.62M | 7.82M | 8.25M |
| EBIT | 104.09M | 83.41M | 84.36M | 10.66M | 54.02M | 66.33M |
| EBIT Margin | 21.00% | 19.04% | 20.03% | 3.46% | 16.72% | 23.66% |
| Effective Tax Rate | 23.70% | 22.48% | 27.64% | 161.99% | 35.07% | 23.10% |
| Advertising Expenses | 605.48K | 752.23K | 889.17K | 966.82K | 963.11K |
Balance sheet
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 39.16M | 11.20M | 32.72M | 15.12M | 24.91M | 19.98M |
| Cash & Short-Term Investments | 39.16M | 11.20M | 32.72M | 15.12M | 24.91M | 19.98M |
| Accounts Receivable | 171.31M | 160.91M | 129.58M | 127.10M | 123.51M | 127.23M |
| Other Receivables | 23.24M | 23.24M | 23.84M | 28.06M | 29.31M | 32.16M |
| Receivables | 194.56M | 184.16M | 153.43M | 155.16M | 152.82M | 159.40M |
| Inventory | 71.15M | 63.56M | 61.84M | 56.83M | 63.67M | 39.36M |
| Prepaid Expenses | 14.53M | 7.90M | ||||
| Other Current Assets | 202.08M | 228.26M | 172.08M | 87.37M | 51.62M | 40.62M |
| Total Current Assets | 506.94M | 487.17M | 420.07M | 314.48M | 307.54M | 267.25M |
| Property, Plant & Equipment | 140.27M | 93.77M | 60.12M | 66.86M | 72.27M | 75.40M |
| Total Assets | 647.21M | 580.94M | 480.19M | 381.34M | 379.82M | 342.65M |
| Accounts Payable | 2.94M | 3.88M | 5.55M | 1.66M | 1.42M | 163.31K |
| Accrued Expenses | 47.03M | 42.83M | 38.23M | 29.72M | 32.13M | 23.69M |
| Short-Term Debt | 17.26M | 27.30M | 18.16M | 11.47M | 986.47K | 304.52K |
| Current Income Taxes Payable | 87.51M | 68.57M | 73.60M | 50.05M | 33.32M | 14.83M |
| Other Current Liabilities | 3.73M | 3.81M | 1.75M | 3.44M | 3.34M | 12.68M |
| Total Current Liabilities | 158.48M | 146.39M | 137.30M | 96.34M | 71.20M | 51.67M |
| Long-Term Deferred Tax Liabilities | 3.40M | 2.19M | 48.39K | 220.75K | 271.55K | |
| Other Long-Term Liabilities | 1.00 | |||||
| Total Liabilities | 161.88M | 148.58M | 137.35M | 96.56M | 71.47M | 51.67M |
| Common Stock | 31.20M | 31.20M | 31.20M | 31.20M | 31.20M | 31.20M |
| Retained Earnings | 420.37M | 367.40M | 311.65M | 253.58M | 275.56M | 257.09M |
| Comprehensive Income & Other | 33.76M | 33.76M | 1.59M | 2.69M | ||
| Shareholders' Equity | 485.33M | 432.36M | 342.85M | 284.78M | 308.35M | 290.98M |
| Total Liabilities & Equity | 647.21M | 580.94M | 480.19M | 381.34M | 379.82M | 342.65M |
| Total Debt | 17.26M | 27.30M | 18.16M | 11.47M | 986.47K | 304.52K |
| Net Cash (Debt) | 21.89M | -16.10M | 14.56M | 3.64M | 23.92M | 19.67M |
| Net Cash Per Share | 7.02 | -5.16 | 4.67 | 1.17 | 7.67 | 6.31 |
| Filing Date Shares Outstanding | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M |
| Total Common Shares Outstanding | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M | 3.12M |
| Working Capital | 348.46M | 340.78M | 282.77M | 218.14M | 236.35M | 215.59M |
| Book Value Per Share | 155.55 | 138.58 | 109.89 | 91.28 | 98.83 | 93.26 |
| Tangible Book Value | 485.33M | 432.36M | 342.85M | 284.78M | 308.35M | 290.98M |
| Tangible Book Value Per Share | 155.55 | 138.58 | 109.89 | 91.28 | 98.83 | 93.26 |
| Land | 36.00M | 36.00M | 80.81K | 80.81K | 80.81K | 80.81K |
| Buildings | 16.67M | 16.16M | 14.29M | 14.29M | 14.29M | 12.57M |
| Machinery | 249.27M | 195.48M | 193.89M | 193.79M | 191.74M | 188.76M |
Cash flow statement
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 77.65M | 63.82M | 61.19M | -6.38M | 34.76M | 50.26M |
| Depreciation & Amortization | 9.51M | 6.50M | 6.92M | 7.62M | 7.82M | 8.25M |
| Other Operating Activities | 752.52K | -4.90M | -4.82M | -6.51M | -3.69M | -4.80M |
| Change in Accounts Receivable | -26.28M | -30.73M | 1.63M | -2.54M | 6.21M | 11.85M |
| Change in Inventory | 14.10M | 10.81M | -17.47M | 6.50M | -15.18M | -27.67M |
| Change in Accounts Payable | 314.72K | -1.67M | 3.89M | 244.88K | 1.25M | -263.43K |
| Change in Other Net Operating Assets | -13.14M | -4.07M | -28.55M | 8.33M | 2.67M | -6.22M |
| Operating Cash Flow | 62.91M | 39.76M | 22.79M | 7.27M | 33.85M | 31.41M |
| Capital Expenditures | -56.17M | -57.13M | -182.71K | -2.21M | -4.70M | -10.28M |
| Sale of Property, Plant & Equipment | 21.00K | 550.00K | ||||
| Sale (Purchase) of Real Estate | -578.00K | -13.53M | ||||
| Other Investing Activities | 109.34K | 200.00K | 371.80K | 4.60M | ||
| Investing Cash Flow | -56.73M | -70.12M | -73.38K | -2.01M | -4.33M | -5.68M |
| Short-Term Debt Issued | 16.49M | 489.46K | 681.95K | |||
| Total Debt Issued | -325.99K | 16.49M | 489.46K | 681.95K | ||
| Short-Term Debt Repaid | -275.84K | -4.78M | ||||
| Total Debt Repaid | -275.84K | -4.78M | ||||
| Net Debt Issued (Repaid) | -325.99K | 16.49M | -275.84K | 489.46K | 681.95K | -4.78M |
| Common Dividends Paid | -9.70M | -7.66M | -4.83M | -15.54M | -25.27M | -15.05M |
| Financing Cash Flow | -10.02M | 8.83M | -5.11M | -15.05M | -24.59M | -19.83M |
| Miscellaneous Cash Flow Adjustments | -1.00 | 1.00 | ||||
| Net Cash Flow | -3.84M | -21.53M | 17.61M | -9.79M | 4.93M | 5.89M |
| Free Cash Flow | 6.74M | -17.37M | 22.60M | 5.06M | 29.15M | 21.12M |
| Free Cash Flow Margin | 1.36% | -3.97% | 5.37% | 1.64% | 9.02% | 7.54% |
| Free Cash Flow Per Share | 2.16 | -5.57 | 7.25 | 1.62 | 9.34 | 6.77 |
| Levered Free Cash Flow | -2.99M | -88.26M | 5.59M | 9.86M | 20.13M | 17.39M |
| Unlevered Free Cash Flow | -1.46M | -87.17M | 5.75M | 10.01M | 20.37M | 17.95M |
| Cash Interest Paid | 2.44M | 1.75M | 258.22K | 239.20K | 239.20K | 899.72K |
| Cash Income Tax Paid | 28.46M | 27.15M | 32.43M | 23.71M | 25.15M | 23.17M |
| Change in Working Capital | -25.00M | -25.66M | -40.50M | 12.54M | -5.05M | -22.30M |
Ratios
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.70B | 1.67B | 2.09B | 2.47B | 2.54B | 1.24B |
| Enterprise Value | 1.68B | 1.65B | 2.04B | 2.46B | 2.50B | 1.23B |
| Last Close Price | 544.60 | 532.40 | 661.81 | 781.79 | 800.73 | 387.17 |
| PE Ratio | 21.88 | 26.18 | 34.09 | 73.14 | 24.70 | |
| PS Ratio | 3.43 | 3.81 | 4.95 | 8.00 | 7.87 | 4.43 |
| PB Ratio | 3.50 | 3.86 | 6.08 | 8.66 | 8.25 | 4.27 |
| P/TBV Ratio | 3.50 | 3.86 | 6.08 | 8.66 | 8.25 | 4.27 |
| P/FCF Ratio | 252.21 | 92.27 | 487.65 | 87.25 | 58.77 | |
| P/OCF Ratio | 27.01 | 42.02 | 91.53 | 339.47 | 75.13 | 39.53 |
| EV/Sales Ratio | 3.38 | 3.77 | 4.84 | 7.97 | 7.74 | 4.38 |
| EV/EBITDA Ratio | 14.77 | 18.36 | 22.34 | 134.45 | 40.46 | 16.47 |
| EV/EBIT Ratio | 16.11 | 19.79 | 24.18 | 230.56 | 46.31 | 18.52 |
| EV/FCF Ratio | 248.96 | 90.22 | 485.99 | 85.84 | 58.15 | |
| Debt / Equity Ratio | 0.04 | 0.06 | 0.05 | 0.04 | 0.00 | 0.00 |
| Debt / EBITDA Ratio | 0.15 | 0.30 | 0.20 | 0.63 | 0.02 | 0.00 |
| Debt / FCF Ratio | 2.56 | 0.80 | 2.27 | 0.03 | 0.01 | |
| Net Debt / Equity Ratio | -0.04 | 0.04 | -0.04 | -0.01 | -0.08 | -0.07 |
| Net Debt / EBITDA Ratio | -0.19 | 0.18 | -0.16 | -0.20 | -0.39 | -0.26 |
| Net Debt / FCF Ratio | -3.25 | -0.93 | -0.64 | -0.72 | -0.82 | -0.93 |
| Asset Turnover | 0.81 | 0.83 | 0.98 | 0.81 | 0.89 | 0.85 |
| Inventory Turnover | 4.73 | 4.88 | 4.92 | 4.27 | 4.26 | 5.48 |
| Quick Ratio | 1.48 | 1.33 | 1.36 | 1.77 | 2.50 | 3.47 |
| Current Ratio | 3.20 | 3.33 | 3.06 | 3.26 | 4.32 | 5.17 |
| Return on Equity (ROE) | 17.19% | 16.46% | 19.50% | -2.15% | 11.60% | 18.32% |
| Return on Assets (ROA) | 10.57% | 9.83% | 12.24% | 1.75% | 9.35% | 12.60% |
| Return on Invested Capital (ROIC) | 17.52% | 16.65% | 20.03% | -2.34% | 12.62% | 19.62% |
| Return on Capital Employed (ROCE) | 21.30% | 19.20% | 24.60% | 3.70% | 17.50% | 22.80% |
| Earnings Yield | 4.57% | 3.82% | 2.93% | -0.26% | 1.37% | 4.05% |
| FCF Yield | 0.40% | -1.04% | 1.08% | 0.21% | 1.15% | 1.70% |
| Dividend Yield | 0.55% | 0.56% | 0.37% | 0.13% | 0.61% | 1.26% |
| Payout Ratio | 12.49% | 12.01% | 7.90% | 72.69% | 29.94% | |
| Total Shareholder Return | 0.55% | 0.56% | 0.37% | 0.13% | 0.61% | 1.26% |